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Background/aim: Measles, mumps, rubella, and varicella can affect susceptible healthcare workers who might subsequently spread the
infection to susceptible patients and workers. Here, we aim to determine the seroprevalence of these infections among physicians and
nurses and to compare the history of varicella with the results of varicella antibodies among study participants.
Materials and methods: Two randomly selected groups, one group of physicians and one of nurses, from a university hospital in Jordan
were interviewed and their serum IgG antibodies were measured.
Results: The physicians and nurses group had 252 and 241 participants, respectively. The physicians group had significantly more males
and younger participants. The percentage of individuals in the physician and nurse groups with positive antibodies to measles was 75.4%
and 75.1%, respectively; mumps, 88.5% and 94.2%; rubella, 89.3% and 87.1%; and varicella, 92.1% and 92.5%. Immunity was similar
between the 2 groups except for mumps, where significantly more nurses were immune. The positive and negative predictive values for
the history of varicella to predict immunity in all participants were 95% and 13.5%, respectively.
Conclusion: A small but important proportion of our healthcare workers are still susceptible to measles, mumps, rubella, and varicella.
In addition, the recall history to varicella showed suboptimal ability to predict immunity.
Key words: Measles, mumps, rubella, varicella, healthcare workers, Jordan

1. Introduction
Measles, mumps, rubella, and varicella remain potential
risks for transmission in healthcare settings. A healthcare
worker (HCW) who lacks immunity is at high risk
for contracting the disease, for complications, and for
transmitting the infection to susceptible patients (1–8).
In Jordan, no data exist on the susceptibility rates
among HCWs for measles, mumps, rubella, or varicella.
Furthermore, to our knowledge, vaccination programs
for these infections are not implemented in most
Jordanian hospitals. Here, we aim first to determine the
seroprevalence of these infections in 2 groups of HCWs:
1 group of physicians and 1 group of nurses working in
a large university hospital in Jordan. Second, we aim to
compare the history of varicella with varicella antibodies
among the study participants. Our data would help in
estimating the risks posed to HCWs by these infections
and in developing vaccination policies in our area.
* Correspondence: fbakri@ju.edu.jo
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2. Methods and materials
The study was conducted at the Jordan University Hospital
(Amman, Jordan), which is a large teaching and tertiary
hospital with 540 bed capacity. It serves both children
and adults with a working staff of 542 physicians and
775 nurses. The hospital has no vaccination program for
HCWs for any of the tested infections.
The study was approved by the hospital’s institutional
review board. We aimed to select 1 group of physicians
and 1 group of nurses. A sample size of around 250
participants in each group of physicians and nurses was
recommended, assuming seroprevalence for the tested
infections of 80%, significance level of 0.05, and accuracy
of 5 percentage points. Systematic sampling was used to
select participants; a list for staff names for each group
was generated and sorted according to alphabetical order.
Selection was conducted by including every second name
in the physician list and every third name in the nurse list.
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In case of refusal or unavailability, the next name in the
list was selected. Investigators interviewed the participants
and collected blood samples.
Collected sera were frozen and later tested using
a commercial enzyme-linked immunosorbent assay.
Blood was tested for IgG antibodies to measles, mumps,
varicella zoster virus (IBL International, Germany), and
rubella (Biorad, France) according to the manufacturer’s
instructions. Equivocal results were considered negative
(9). Participants were informed about their results and
those who had seronegative results were advised to take
the appropriate vaccines.
Seroprevalence was calculated for each group of
physicians and nurses and for the combined 2 groups.
For analysis, we used the chi-square test for proportion
data and the Mann–Whitney U test for nonparametric
data. Results were considered statistically significant if the
2-tailed P-value was <0.05. Statistical analysis was done
with SPSS 16. Seroprevalence and the predictive value of
history of varicella infection were calculated as previously
described (8,10).
3. Results
The study was performed between March 2011 and March
2012. Sixty-two HCWs (27 physicians and 35 nurses)
refused to participate and 5 HCWs were found to have
resigned. We excluded 7 blood samples because names
on the blood samples were missing. Out of 1972 tests, 156
(8%) gave an equivocal result. Equivocal results accounted
for 59.8% of the negative samples.

3.1. Characteristics of study participants
The total number of participants was 493 (252 physicians
and 241 nurses). All participants were Jordanian. Overall
mean age was 30 years (SD: ±7.3; range: 22–67). The
physician group had significantly more males and younger
participants than the nurse group (Table 1).
3.2. Seroprevalence and associated factors
The total number of participants with antibodies to
measles was 371 (75.3%), mumps 450 (91.3%), rubella 435
(88.2%), and varicella 455 (92.3%) (Table 1). Immunity
to tested diseases was similar between the physician and
nurse groups except for mumps, where significantly more
nurses were immune (P = 0.025) (Table 1). A total of 5
participants were born before 1957 (4 male physicians and
1 male nurse), and all had protective antibodies to all tested
diseases. Of all participants, 184 (97 physicians, 87 nurses;
37%) had no immunity to at least 1 of the 3 infections –
measles, mumps, or rubella – for which a single combined
vaccine formulation is available, and 202 (105 physicians,
97 nurses) participants (40%) had no immunity to at least
1 of the 4 tested infections.
Testing for associations between immunity and age
or sex showed that, in the physician group, immunity
to measles significantly increased with age, whereas in
the nurse group, immunity to both measles and mumps
significantly increased with age and females were more
likely to be immune to measles (Table 2). In addition, after
separating the participants according to birthdate before or
after the year 1982 (the year in which the measles vaccine
was introduced into the national vaccination program),

Table 1. Characteristics and seroprevalence of both study groups.

Males (%)

Physicians
n = 252 n (%)

Nurses
n = 241 n (%)

Pa

170 (67.5%)

67 (27.8%)

0.000*

185 (73.4%)
53 (21.0%)
8 (3.2%)
6 (2.4%)
28.8 ± 6.3
27
22–67

125 (51.9%)
65 (27.0%)
46 (19.1%)
5 (2.1%)
31.4 ± 7.9
29
22–57

0.000*

190 (75.4%)

181 (75.1%)

0.940

223 (88.5%)

227 (94.2%)

0.025*

225 (89.3%)

210 (87.1%)

0.459

232 (92.1%)

223 (92.5%)

0.846

Age, years
<30
30–39
40–49
>50
Mean ± SD
Median
Range
Measles
Immune
Mumps
Immune
Rubella
Immune
Varicella
Immune
*Significant P-value;

Chi-square test.

a
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those who were born before 1982 were significantly more
immune to measles than those who were born after 1982.
In the physician group, seropositivity was 42/45 (93.3%)
and 148/207 (71.5%) for those born before and after 1982,
respectively (P = 0.002); in the nurse group, seropositivity
was 95/102 (93.1%) and 87/140 (62.1%) for those born
before and after 1982, respectively (P = 0.000) (Table 3).
Regarding rubella, 23 out of 213 (11%) of female HCWs at
childbearing age (≤39 years) had no immunity (Table 4).
3.3. Recall history of varicella
Recall history of varicella and the results of the serological
testing for each group of physicians and nurses are shown
in Table 5. The sensitivity, specificity, positive predictive
value (PPV), and negative predictive value (NPV) of the
recall history in predicting immunity by serological testing
for the physicians group were 85.7% [156/(26 + 156)],
42.8% [6/(6 + 8)], 95.1% [156/164], and 18.7% [6/32],
respectively, while for the nurse group they were 68.3%,

50%, 94.8%, and 10.5% (Table 6). When participants with
an unknown history of varicella were included in the group
with a negative history of varicella infection, the sensitivity
and specificity became 67.2% and 60%, respectively, for
physicians and 49.3% and 66.7% for nurses (Table 6).
4. Discussion
Here, the seroprevalence for measles was 75.4%, 75.1%,
and 75.3% for the physicians, nurses, and the combined
groups, respectively; mumps, 88.5%, 94.2%, and 91.3%;
rubella, 89.3%, 87.1%, and 88.2%; and varicella, 92.1%,
92.5%, and 92.3%. Available seroprevalence studies from
neighboring areas are scarce and show a range from 87%
to 91% for measles (11–13), 92%–93% for mumps (12,13),
90%–98% for rubella (11–13), and 71%–98.5% for varicella
(11–18). Therefore, our results, except for measles, are
within the regional range. However, such results in
healthcare workers might be unsatisfactory, since these

Table 2. Seropositivity according to sex and age in the physician and nurse groups.
Physicians

Measles

Mumps

Rubella

Varicella

Nurses

Seropositivity (%)

P

Males

127/170 (74.7)

0.714

Females

63/82 (76.8)

Age, median (IQR) years

a

P

44/67 (65.7)

0.036* a

137/174 (78.7)
0.000*

0.000*b

b

Immune

28.0 (25.0–30.0)

32.0 (26.0–40.0)

Susceptible

26.0 (24.0–28.0)

25.0 (23.0–28.8)

Males

151/170 (88.8)

63/67 (94.0)

Females

72/82 (87.8)

0.812 a

164/174 (94.3)

1.000 a

Immune

27.0 (25.0–30.0)

0.842 b

30.0 (25.0–38.0)

0.002*b

Susceptible

27.0 (26.0–29.0)

Males

151/170 (88.8)

Females

74/82 (90.2)

Age, median (IQR) years

Age, median (IQR) years
Immune

27.0 (25.0–30.0)

Susceptible

27.0 (24.0–30.0)

Males

156/170 (91.8)

Females

76/82 (92.7)

Age, median (IQR) years

24.0 (23.0–27.0)
0.733

a

0.236

b

60/67 (89.6)

0.487 a

150/174 (86.2)
0.698 b
29.0 (24.0–38.0)
32.0 (25.0–40.0)
0.801

a

0.253

b

62/67 (92.5)

0.998 a

161/174 (92.5)
0.691 b

Immune

27.0 (25.0–30.0)

29.0 (24.0–38.0)

Susceptible

26.0 (25.0–28.5)

28.0 (24.8–40.5)

IQR: interquartile range. * Significant P-value. aChi-square test. bMann–Whitney U test.
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Table 3. Seropositivity to measles in participants born before and after 1982.
Physicians

Nurses

Seropositivity

P-value

Seropositivity

P-value

Born before 1982

42/45 (93.3%)

0.002*

95/102 (93.1%)

0.000* a

Born after 1982

148/207 (71.5%)

a

87/140 (62.1%)

*Significant P-value. aChi-square test.
Table 4. Rubella seronegativity according to the age groups in female HCWs.

Age group in years

Seronegativity in females (%)
Physicians

Nurses

Total

<30

8/66 (12.1%)

9/87 (9.2%)

17/153 (10.5%)

30–39

0/16 (0%)

7/43 (15.9%)

7/59 (11.7%)

40–49

0/0 (0%)

7/41 (17.1%)

7/41 (17.1%)

>50

0/0 (0%)

1/3 (33.3%)

1/3 (33.3%)

Total

8/82 (9.8%)

24/174 (13.1%)

32/256 (12.1%)

Table 5. Results for serological testing and recall history of varicella.

Physicians

Nurses

History of varicella

Varicella IgG negative (%)

Varicella IgG positive (%)

Total

Positive

8 (4.8%)

156 (96.1%)

164

Negative

6 (18.7%)

26 (81.2%)

32

Unknown

6 (10.7%)

50 (89.2%)

56

Positive

6 (5.1%)

110 (94.8%)

116

Negative

6 (10.5%)

51 (89.4%)

57

Unknown

6 (8.8%)

62 (91.1%)

68

Table 6. The validity of recall history for detecting varicella immunity.
Physicians

Nurses

Physicians and nurses

Sensitivity

85.7%

68.3%

77.5%

Specificity

42.8%

50.0%

46.2%

PPV

95.1%

94.8%

95.0%

NPV

18.7%

10.5%

13.5%

Sensitivity (neg + u)

67.2%

49.3%

58.5%

Specificity (neg + u)

60.0%

66.7%

63.2%

Sensitivity (neg + u): sensitivity when people with unknown histories were added to those with a negative history. Specificity (neg + u):
specificity when people with unknown histories were added to those with a negative history.
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infections are highly transmissible and require very high
population-level immunity (19). There was no significant
difference in immunity between the physician and nurse
groups except for mumps, where more nurses (94.2%)
than physicians (88.5%) (P = 0.025) were immune, which
could be due to the older age of participating nurses.
The finding that immunity to measles and mumps
increases with age has been previously reported and was
attributed to the possible low uptake of vaccine and the
low exposure among the young age group (7,20–23).
This explanation is further supported herein by finding
significantly more immunity in participants born before
the introduction of the measles vaccine in 1982 than
in those born later. In addition, our finding that all 5
participants born before 1957 were immune to the tested
infections is consistent with the Centers for Disease Control
and Prevention definition, which states that persons born
before 1957 are considered to have acceptable presumptive
evidence of immunity to measles, rubella, and mumps (9).
In this study, the overall immunity rate to rubella was
88% (Table 1) and that for women of childbearing age
was 89% (Table 3). These results are in accordance with 2
earlier community studies in Jordan: the first found that
the overall immunity to rubella was 81% for women aged
15–35 years (24). The second found that the immunity for
women from 15 to 49 years was 91%, but that for women
aged 15–19 years, it dropped to 83% (25). These findings
are significant because the incidence of congenital rubella
in a given population depends on the number of susceptible
individuals, the circulation of virus in the community, and
the use of the rubella vaccine (26).
Our results also indicate that the PPV of the recalled
history of varicella (95% for the overall participants) is

not high enough to safely consider those with a positive
varicella history to be immune, since 14 of the 280
participants (5%) with a positive history of varicella
were found to be seronegative. Moreover, the NPV of the
recalled history of varicella (13.5% for all participants) was
poor, meaning that a negative history of varicella was able
to correctly identify only a few susceptible participants.
For all participants, a negative or unknown history
against varicella was able to detect 63% of seronegative
participants, whereas 37% of seronegative participants
were not detected by history. Therefore, to avoid missing
seronegative HCWs, we recommend that all HCWs in our
institution be tested for immunity against varicella and
those who test seronegative should receive the varicella
vaccine.
Our study is mainly limited by being conducted at a
single healthcare facility. However, since our hospital serves
a wide range of Jordan’s population and the employees are
all Jordanian, we think that our results are applicable to
and representative of HCWs throughout the country.
In conclusion, among our population of HCWs,
rates of immunity to measles are low, while those to
mumps, rubella, and varicella are relatively high but still
unsatisfactory. This highlights the need to establish policies
to ensure protective immunity through testing, followed by
vaccination of seronegative staff. Recall history of varicella
poorly detected immunity to varicella, suggesting that the
best approach to ensure acceptable levels of immunity to
varicella is to test all HCWs for this virus and vaccinate
those who are seronegative.
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